OPN-6602 Currently Treating Patients in Phase 1 Clinical Trial SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--April 15, 2026-- Opna Bio, a clinical-s ...
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva,” the “Company” “we” or “us”), a late-stage pharmaceutical ...
Through the collaboration, Silicon Box will work with industry leaders to advance automotive-grade chiplet devices with advanced packaging.
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva," the "Company" "we" or "us"), a late-stage pharmaceutical company developing therapies ...
Shares end at the highest since March 2; Virgin Australia reaffirms guidance; Nufarm rises the most since 2023; UBS; Mesoblast rises on licensing deal. Follow live.
Wayve has raised $60M from AMD, Arm, and Qualcomm Ventures, extending its $1.2B Series D. Robotaxi pilots with Uber are ...
As the bulk sector navigates tariffs, costs, and regulatory shifts, NTTC’s 2026 Annual Conference aims to foster industry ...